Epeius


Also found in: Wikipedia.

Epeius

designer and builder of the Trojan Horse. [Rom. Lit.: Aeneid]
Mentioned in ?
References in classic literature ?
The Trojans are now closely beseiged, and Epeius, by Athena's instruction, builds the wooden horse.
Sant Chawla Sarcoma Center in Santa Monica, California, and the care givers at EPEIUS Bio Technology Clinic in Manila, Philippines.
Epeius Biotechnologies Corporation (San Marino, CA), a leader in tumor-targeted gene delivery systems, has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body.
This does not strike us as immediately associated with the tale of the Trojan horse, though the previous history of Epeius might bear further investigation.
Abraxis BioScience - Access Pharmaceuticals - Alnylam Pharmaceuticals - Arrowhead Research - BIND Biosciences - Epeius Biotechnologies - Nanobiotix - NanoCarrier - Nippon Kayaku - Samyang - Takeda Pharmaceutical
Epeius Biotechnologies Corporation (San Marino, CA) announced the issue of United States Patent 7,347,998 for Targeted Gene Delivery in vivo.
Emergent Biosolutions - Enzo Biochem - Epeius Biotechnologies - Errant Gene Therapeutics - ESTEVE - Etubics Corporation - FKD Therapies Oy - Fondazione Telethon - Genable Technologies - Gene Medicine Japan - GeneCure Biotechnologies - Genelux Corporation - GeneOne Life Sciences - GeneSight Biologics - Genethon - Genexine - Genprex - GenVec - Genzyme - GeoVax Inc.
and Epeius Biotechnologies Corporation are likely to become major players in the future osteosarcoma therapeutics market.
don Cold Genesys Cook Biotech Incorporated CryoCenter Saint-Petersburg CytoMedix Cytori Therapeutics Daiichi Sankyo Dendreon DePuy Mitek (subsidiary of Johnson & Johnson) Epeius Biotechnologies
don Cold Genesys Cook Biotech Incorporated CryoCenter Saint-Petersburg CytoMedix Cytori Therapeutics Daiichi Sankyo Dendreon DePuy Mitek (subsidiary of Johnson & Johnson) Epeius Biotechnologies EyeCyte Fibrocell Science Gamida Cell Ltd Gemabank Genpharm Genzyme (subsidiary of Sanofi) Geron Histogenics Humacyte Human Stem Cells Institute Insulete Inc Introgen Therapeutics ISTO Technologies Japan Tissue Engineering Co.
Epeius Receives BFAD Approval for Expanded Access Program for
New Drug Developments and Launches II-68 GSK Launches Cervarix in Singapore II-68 Abeome Launches New Stem Cell Monoclonal Antibody II-68 Dabur Pharma Launches a New Drug Delivery System, Nanoxel II-68 Epeius Biotechnologies Develops New Targeted Anti-Cancer Drugs II-68 Monash University Scientists Develop siRNA for Cancer Treatment II-69 Cytogen Introduces SOLTAMOX[TM], the First Hormonal Breast Cancer Therapy II-69